Logo
x

Search category

Subscribe Now

All Posts by Date

Veracyte Signs a Multi-Year Agreement with AstraZeneca

Veracyte Signs a Multi-Year Agreement with AstraZeneca

  • January 9, 2020
Merck & Co's Keytruda (pembrolizumab) Receives the US FDA's Approval for Patients with BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer

Merck & Co's Keytruda (pembrolizumab) Receives the US FDA's Approval for Patients with BCG-Unresponsive High-Risk Non-Muscle I...

  • January 9, 2020
Almirall Signs an In-License Agreement with 23andMe for Multiple Inflammatory Diseases

Almirall Signs an In-License Agreement with 23andMe for Multiple Inflammatory Diseases

  • January 9, 2020
Mylan Voluntarily Recalls Nationwide Three Lots of Nizatidine Capsules USP Due to Trace Amounts of NDMA (N-Nitrosodimethylamine)

Mylan Voluntarily Recalls Nationwide Three Lots of Nizatidine Capsules USP Due to Trace Amounts of NDMA (N-Nitrosodimethylamine)

  • January 9, 2020
Evotec Signs a Five-Year Collaboration with Bayer to Develop Therapies for Polycystic Ovary Syndrome

Evotec Signs a Five-Year Collaboration with Bayer to Develop Therapies for Polycystic Ovary Syndrome

  • January 9, 2020
BioMed Collaborates with Merck & Co for Autoimmune Diseases

BioMed Collaborates with Merck & Co for Autoimmune Diseases

  • January 9, 2020
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.